3,5-Dihydroxybenzoic Acid

3,5-Dihydroxybenzoic Acid

SCHEMBL618767

O=C(O)c1cc(O)cc(O)c1.O=C(O)c1cc(O)cc(O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 1.00
CA1 P00915 5/20 1.00
CA2 P00918 5/20 1.00
CA9 Q16790 5/20 1.00
CA7 P43166 4/20 1.00
CA14 Q9ULX7 4/20 1.00
HCAR1 Q9BXC0 3/20 0.68
CA5A P35218 3/20 0.57
CA6 P23280 3/20 0.57
CA3 P07451 2/20 0.57
CA4 P22748 2/20 0.57
CA5B Q9Y2D0 2/20 0.57
TP53 P04637 2/20 0.57
ALDH1A1 P00352 2/20 0.57
MAPT P10636 2/20 0.57
HPGD P15428 2/20 0.57
MAPK1 P28482 2/20 0.57
TDP1 Q9NUW8 2/20 0.57
KDM4E B2RXH2 1/20 0.57
LMNA P02545 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3,5-Dihydroxybenzoic Acid SCHEMBL28106 1.00 CA12 (1.00) CA12CA1CA2CA9CA7
3,5-Dihydroxybenzoic Acid SCHEMBL10936753 0.97 CA12 (0.94) CA12CA1CA2CA9CA7
3,5-Dihydroxybenzoic Acid SCHEMBL32679272 0.97 CA12 (0.94) CA12CA1CA2CA9CA7
3,5-Dihydroxybenzoic Acid SCHEMBL1151737 0.97 CA12 (0.94) CA12CA1CA2CA9CA7
3,5-Dihydroxybenzoic Acid SCHEMBL9693437 0.97 CA12 (0.94) CA12CA1CA2CA9CA7
3,5-Dihydroxybenzoic Acid SCHEMBL5695849 0.97 CA12 (0.94) CA12CA1CA2CA9CA7
SCHEMBL139644 0.94 CA12 (0.88) CA12CA1CA2CA9CA7
Phloroglucinol SCHEMBL21465836 0.94 CA12 (0.88) CA12CA1CA2CA9CA7
Methane SCHEMBL6131088 0.91 CA12 (0.83) CA12CA1CA2CA9CA7
SCHEMBL31390821 0.91 CA12 (0.83) CA12CA1CA2CA9CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120041033-A1 HYDROXYBENZOATE SALTS OF METANICOTINE COMPOUNDS MUNOZ JULIO A (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120041033-A1 HYDROXYBENZOATE SALTS OF METANICOTINE COMPOUNDS MAOB, SLC6A3, HTT CA12 4467/4885CA1 4681/4885CA2 4483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.